Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease ContinuumAndréa Lessa Benedet, Alyssa Stevensson, Natàlia Vilor‐Tejedor et al.|JAMA Neurology|2021Cited by 627
APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic casesHélène-Marie Lanoiselée, Gaël Nicolas, David Wallon et al.|PLoS Medicine|2017Cited by 610
Neprilysin, cardiovascular, and Alzheimer's diseases: the therapeutic split?Nicolas Vodovar, Alain Cohen‐Solal, Claire Paquet et al.|European Heart Journal|2015Cited by 75
Le phénotype clinique initial a-t-il un impact sur le pronostic dans la maladie à corps de Lewy ?Clément Aveneau, Claire Paquet, David Wallon et al.|Revue Neurologique|2024Cited by 0